Muthukumaraswamy S

LSD reconfigures cortical dynamics through faster brain rhythms and increased fractal dimension.

Subramani V, Nest T, Pascarella A +8

ArticlePsilocybin

An Open-Label Trial Protocol to Test Menstrual Cycle Effects and Tolerance to Low-Dose Psilocybin in Healthy Menstruating Persons.

Kothiwala FM, Murphy RJ, Alshakhouri M +5

LSD Relaxes Structural Constraints on Brain Dynamics: A Connectome Harmonic MEG Study

Subramani V, Pascarella A, Brunel J +6

LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a Phase 2a trial.

Daldegan-Bueno D, Donegan CJ, Sumner R +11

LSD Reconfigures Cortical Dynamics Through Faster Brain Rhythms and Increased Fractal Dimension

Subramani V, Nest T, Pascarella A +8

What is it like to microdose LSD for depression? a thematic analysis of participant interviews from an open-label trial.

Joy Donegan C, Daldegan-Bueno D, Sumner RL +7

LSD microdosing in major depressive disorder: results from an open-label trial.

Daldegan-Bueno D, Donegan CJ, Sumner R +12

A Novel Stability Indicating High Performance Liquid Chromatography Method for Lysergic Acid Diethylamide Quantification: From Microdosing Applications to Broader Analytical Use.

Bansal M, Miller E, Sumner R +3

Qualitative content analysis of expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measures.

Donegan CJ, Daldegan-Bueno D, Noorani T +9

The Role of the Dorsolateral Prefrontal Cortex in Ego Dissolution and Emotional Arousal During the Psychedelic State.

Coleman CR, Shinozuka K, Tromm R +7

LSD reconfigures the frequency-specific network landscape of the human brain

Shinozuka K, Rosso M, Coleman CR +8

Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms

Hodge A, Forsyth A, Noorani T +3

Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms

Hodge A, Forsyth A, Noorani T +3

LSD flattens the hierarchy of directed information flow in fast whole-brain dynamics.

Shinozuka K, Tewarie PKB, Luppi A +7

The Role of the Dorsolateral Prefrontal Cortex in Ego Dissolution and Emotional Arousal During the Psychedelic State

Coleman CR, Shinozuka K, Tromm R +7

Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms

Hodge A, Forsyth A, Noorani T +3

Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms

Hodge A, Forsyth A, Noorani T +3

Multimodal creativity assessments following acute and sustained microdosing of lysergic acid diethylamide.

Murphy RJ, Sumner RL, Godfrey K +4

LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder.

Daldegan-Bueno D, Donegan CJ, Forsyth A +16

LSD flattens the hierarchy of directed information flow in fast whole-brain dynamics

Shinozuka K, Tewarie PK, Luppi A +7

LSD increases sleep duration the night after microdosing.

Allen N, Jeremiah A, Murphy R +8

Modulation of long-term potentiation following microdoses of LSD captured by thalamo-cortical modelling in a randomised, controlled trial.

Murphy RJ, Godfrey K, Shaw AD +2

Microdosing Psychedelics: Current Evidence From Controlled Studies.

Murphy RJ, Muthukumaraswamy S, de Wit H

Effects of External Stimulation on Psychedelic State Neurodynamics.

Mediano PAM, Rosas FE, Timmermann C +10

The entropic heart: Tracking the psychedelic state via heart rate dynamics

Rosas FE, Mediano PA, Timmermann C +9

An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).

Donegan CJ, Daldegan-Bueno D, Sumner R +15

ArticlePsychedelics

Dark loops: contagion effects, consistency and chemosocial matrices in psychedelic-assisted therapy trials.

Noorani T, Bedi G, Muthukumaraswamy S

Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled Trial.

Murphy RJ, Sumner R, Evans W +10

ArticleKetamine

Psychedelics and schizophrenia: Distinct alterations to Bayesian inference.

Rajpal H, Mediano PAM, Rosas FE +7

Europe PMC2022

ArticlePsychedelics

Cancer Healthcare Workers' Perceptions toward Psychedelic-Assisted Therapy: A Preliminary Investigation.

Reynolds LM, Akroyd A, Sundram F +3

Europe PMC2021

MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers.

Murphy RJ, Sumner RL, Evans W +8

Europe PMC2021

Blinding and Expectancy Confounds in Psychedelic Randomised Controlled Trials

Muthukumaraswamy S, Forsyth A, Lumley T

Europe PMC2021

ArticleDMT

Neural correlates of the DMT experience assessed with multivariate EEG.

Timmermann C, Roseman L, Schartner M +13

Europe PMC2019

ArticlePsilocybin

Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives.

Pallavicini C, Vilas MG, Villarreal M +5

Europe PMC2019